Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
SCIELE PHARMA, INC. (SCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/09/2008 8-K Quarterly results
09/03/2008 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Agreement and Plan of Merger, among Shionogi & Co., Ltd., Tall Bridge, Inc. and Sciele Pharma, Inc.",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Patrick Fourteau",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Edward Schutter",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Darrell Borne",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Leslie Zacks",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Larry Dillaha",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Joseph Ciaffoni",
"SHIONOGI & CO., LTD. TO ACQUIRE SCIELE PHARMA, INC. SIGNIFICANTLY INCREASES SHIONOGI'S PRESENCE IN THE UNITED STATES",
"Form of Tender and Voting Agreement"
08/27/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Agreement between the Company and Joseph Ciaffoni"
07/30/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR THE SECOND QUARTER OF 2008 Second quarter 2008 financial results include:"
07/01/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA SIGNS AGREEMENT WITH ADDRENEX PHARMACEUTICALS TO DEVELOP AND MARKET ADX415 FOR THE TREATMENT OF HYPERTENSION"
05/23/2008 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Elimination"
04/30/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR THE FIRST QUARTER OF 2008 First quarter 2008 financial results include:"
04/28/2008 8-K Material Modifications to Rights of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Sciele Pharma, Inc. Adopts $100 Million Share Repurchase Program ———————— Approves Redemption of Poison Pill"
03/14/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ACQUIRES TWINJECT EPINEPHRINE AUTO-INJECTOR FROM VERUS PHARMACEUTICALS"
03/11/2008 8-K Changes in Registrant.s Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter of BDO Seidman, LLP to the Securities and Exchange Commission",
"SCIELE PHARMA, INC. ANNOUNCES CHANGE OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS"
02/27/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2007",
"Letter from BDO Seidman, LLP to the Commission"
02/21/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE AND ADDRENEX ANNOUNCE NDA SUBMISSION OF CLONIBID TO TREAT HYPERTENSION SCIELE PROVIDES UPDATE ON HEAD LICE ASPHYXIATION PRODUCT"
02/21/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA AND LIFECYCLE PHARMA ANNOUNCE U.S. MARKET LAUNCH OF FENOGLIDE™ ————————— NEW FORMULATION OF FENOFIBRATE IN 120-MG. AND 40-MG. DOSAGE STRENGTHS"
01/09/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "SCIELE EXPECTS TO LAUNCH SIX PRODUCTS IN 2008; REAFFIRMS REVENUE AND EPS GUIDANCE FOR FULL-YEARS 2007 AND 2008"
01/04/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ANNOUNCES FDA APPROVAL OF NEW SULAR® FORMULATION"
12/31/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Agreement between the Company and Patrick Fourteau",
"Employment Agreement between the Company and Edward Schutter",
"Employment Agreement between the Company and Darrell Borne",
"Employment Agreement between the Company and Leslie Zacks",
"Employment Agreement between the Company and Larry Dillaha"
12/07/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/05/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "EDWARD J. SCHUTTER APPOINTED TO PRESIDENT AND CHIEF OPERATING OFFICER OF SCIELE PHARMA, INC."
11/19/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE SIGNS EXCLUSIVE AGREEMENT WITH NOVO NORDISK TO MARKET PRANDIN® AND PRANDIMET®"
11/05/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE REPORTS THAT FDA EXTENDS PDUFA DATE ON NEW SULAR FORMULATION TO JANUARY 2, 2008"
10/30/2007 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS REVENUES AND EARNINGS FOR THE THIRD QUARTER OF 2007"
09/12/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Amended Schedule A to Patrick Fourteau's 10b5-1 Sales Plan"
08/24/2007 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "FINANCIAL STATEMENTS OF BUSINESS ACQUIRED.",
"PRO FORMA FINANCIAL INFORMATION",
"CONSENT OF INDEPENDENT AUDIORS"
08/07/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA, INC. ADOPTS $40 MILLION SHARE REPURCHASE PROGRAM"
07/25/2007 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS REVENUES AND EARNINGS FOR THE SECOND QUARTER 2007"
07/19/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ACQUIRES A NOVEL, PATENTED TREATMENT FOR HEAD LICE FROM SUMMERS LABORATORIES, INC."
07/19/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA SIGNS AGREEMENT WITH ADDRENEX PHARMACEUTICALS TO MARKET CLONICEL®"
06/20/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA LAUNCHES PRENATE DHA, A PRESCRIPTION PRENATAL AND POSTNATAL MULTIVITAMIN WITH DHA AND METAFOLIN IN ONE CAPSULE"
06/15/2007 8-K Other Events
06/15/2007 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA COMPLETES REDEMPTION OF ALL $150 MILLION NEW 1.75% CONTINGENT CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2024"
06/13/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "First Amendment to Agreement and Plan of Merger",
"SCIELE PHARMA COMPLETES ACQUISITION OF ALLIANT PHARMACEUTICALS"
05/17/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ANNOUNCES REDEMPTION OF ALL $150 MILLION 1.75% CONTINGENT CONVERTIBLE SENIOR SUBORDINATED NOTES DUE 2024"
05/17/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF NEW SULAR FORMULATION CLINICAL TRIAL PROGRAM"
05/17/2007 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "INDENTURE"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy